Mark Smeltzer
Concepts (356)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Staphylococcus aureus | 68 | 2023 | 361 | 14.430 |
Why?
| Biofilms | 49 | 2023 | 200 | 10.310 |
Why?
| Bacterial Proteins | 41 | 2023 | 454 | 10.140 |
Why?
| Staphylococcal Infections | 37 | 2023 | 300 | 7.750 |
Why?
| Trans-Activators | 20 | 2021 | 147 | 6.040 |
Why?
| Gene Expression Regulation, Bacterial | 31 | 2023 | 244 | 5.660 |
Why?
| Osteomyelitis | 18 | 2023 | 122 | 5.220 |
Why?
| Anti-Bacterial Agents | 32 | 2023 | 820 | 4.810 |
Why?
| Peptide Hydrolases | 10 | 2023 | 67 | 4.650 |
Why?
| Virulence Factors | 10 | 2021 | 92 | 3.570 |
Why?
| Mutation | 26 | 2023 | 1501 | 2.560 |
Why?
| Daptomycin | 10 | 2016 | 33 | 2.380 |
Why?
| Virulence | 15 | 2023 | 194 | 2.240 |
Why?
| Methicillin-Resistant Staphylococcus aureus | 7 | 2018 | 88 | 1.980 |
Why?
| Protein Kinases | 4 | 2019 | 89 | 1.690 |
Why?
| Chitosan | 8 | 2021 | 34 | 1.510 |
Why?
| Polymethyl Methacrylate | 5 | 2019 | 28 | 1.340 |
Why?
| Animals | 45 | 2023 | 14385 | 1.250 |
Why?
| Phenotype | 8 | 2021 | 820 | 1.240 |
Why?
| Microbial Sensitivity Tests | 16 | 2023 | 290 | 1.180 |
Why?
| Mice | 32 | 2023 | 6413 | 1.170 |
Why?
| Disease Models, Animal | 19 | 2021 | 1639 | 1.090 |
Why?
| Xylitol | 3 | 2012 | 7 | 1.070 |
Why?
| Vancomycin | 13 | 2021 | 88 | 1.050 |
Why?
| Endopeptidases | 2 | 2023 | 75 | 1.000 |
Why?
| Gold | 5 | 2018 | 164 | 0.990 |
Why?
| Catheter-Related Infections | 9 | 2016 | 55 | 0.980 |
Why?
| Prosthesis-Related Infections | 4 | 2019 | 111 | 0.960 |
Why?
| Drug Delivery Systems | 4 | 2021 | 151 | 0.920 |
Why?
| Bacterial Infections | 3 | 2018 | 105 | 0.880 |
Why?
| Bacteremia | 4 | 2017 | 101 | 0.880 |
Why?
| Gene Expression Regulation, Enzymologic | 2 | 2016 | 206 | 0.880 |
Why?
| Bacterial Toxins | 5 | 2020 | 61 | 0.870 |
Why?
| Nanoparticles | 3 | 2022 | 173 | 0.850 |
Why?
| Nanostructures | 2 | 2016 | 53 | 0.800 |
Why?
| Proteomics | 3 | 2019 | 343 | 0.790 |
Why?
| Bone Regeneration | 1 | 2021 | 71 | 0.770 |
Why?
| Repressor Proteins | 2 | 2021 | 165 | 0.760 |
Why?
| Drug Carriers | 6 | 2017 | 81 | 0.700 |
Why?
| Deoxyribonucleases | 3 | 2015 | 24 | 0.640 |
Why?
| Rabbits | 8 | 2021 | 425 | 0.640 |
Why?
| Fluorodeoxyglucose F18 | 2 | 2012 | 205 | 0.640 |
Why?
| Communicable Diseases | 1 | 2018 | 58 | 0.600 |
Why?
| Proteome | 1 | 2018 | 178 | 0.580 |
Why?
| Enterotoxins | 1 | 2016 | 12 | 0.580 |
Why?
| Sigma Factor | 2 | 2016 | 24 | 0.580 |
Why?
| Recombinases | 1 | 2016 | 8 | 0.570 |
Why?
| Humans | 44 | 2023 | 54284 | 0.560 |
Why?
| Peptides, Cyclic | 1 | 2016 | 44 | 0.560 |
Why?
| Hemolysin Proteins | 3 | 2011 | 17 | 0.550 |
Why?
| Cephalosporins | 1 | 2016 | 32 | 0.550 |
Why?
| Serine Endopeptidases | 2 | 2014 | 57 | 0.540 |
Why?
| Host-Pathogen Interactions | 2 | 2016 | 143 | 0.530 |
Why?
| Extracellular Space | 4 | 2021 | 43 | 0.530 |
Why?
| Genetic Loci | 1 | 2015 | 58 | 0.510 |
Why?
| Cysteine Endopeptidases | 1 | 2014 | 75 | 0.500 |
Why?
| Transcription Factors | 5 | 2015 | 622 | 0.490 |
Why?
| Amikacin | 4 | 2018 | 19 | 0.490 |
Why?
| Coated Materials, Biocompatible | 5 | 2022 | 40 | 0.480 |
Why?
| Adhesins, Bacterial | 5 | 2012 | 30 | 0.480 |
Why?
| Delayed-Action Preparations | 2 | 2016 | 50 | 0.470 |
Why?
| Plant Extracts | 2 | 2012 | 193 | 0.460 |
Why?
| RNA, Bacterial | 7 | 2011 | 58 | 0.460 |
Why?
| Hyaluronoglucosaminidase | 1 | 2013 | 6 | 0.460 |
Why?
| Quercus | 1 | 2012 | 8 | 0.450 |
Why?
| Gene Expression Profiling | 4 | 2009 | 1138 | 0.440 |
Why?
| Radius | 1 | 2012 | 27 | 0.430 |
Why?
| Ellagic Acid | 1 | 2012 | 6 | 0.420 |
Why?
| Rosaceae | 1 | 2012 | 9 | 0.420 |
Why?
| Osteoblasts | 3 | 2020 | 514 | 0.400 |
Why?
| Metalloendopeptidases | 3 | 2020 | 82 | 0.400 |
Why?
| Surgical Wound Infection | 1 | 2012 | 126 | 0.400 |
Why?
| Radiopharmaceuticals | 1 | 2012 | 238 | 0.390 |
Why?
| Musculoskeletal Diseases | 2 | 2019 | 40 | 0.390 |
Why?
| DNA, Bacterial | 4 | 2009 | 172 | 0.380 |
Why?
| Pseudomonas aeruginosa | 5 | 2019 | 86 | 0.380 |
Why?
| RNA-Binding Proteins | 2 | 2012 | 136 | 0.380 |
Why?
| Mice, Inbred C57BL | 5 | 2020 | 1999 | 0.370 |
Why?
| Epistasis, Genetic | 1 | 2010 | 42 | 0.370 |
Why?
| Bone Cements | 3 | 2019 | 33 | 0.360 |
Why?
| Operon | 3 | 2016 | 38 | 0.360 |
Why?
| Durapatite | 2 | 2021 | 27 | 0.330 |
Why?
| Positron-Emission Tomography | 2 | 2012 | 322 | 0.320 |
Why?
| RNA, Messenger | 6 | 2011 | 1202 | 0.320 |
Why?
| Genome, Bacterial | 2 | 2009 | 141 | 0.320 |
Why?
| Rifampin | 2 | 2018 | 57 | 0.310 |
Why?
| DNA-Binding Proteins | 3 | 2009 | 462 | 0.310 |
Why?
| Mutagenesis | 1 | 2007 | 77 | 0.300 |
Why?
| Gentamicins | 2 | 2021 | 36 | 0.280 |
Why?
| Arthritis, Infectious | 2 | 2006 | 42 | 0.280 |
Why?
| Glycine | 1 | 2006 | 70 | 0.280 |
Why?
| Joint Prosthesis | 1 | 2005 | 14 | 0.270 |
Why?
| Nanotechnology | 1 | 2005 | 39 | 0.270 |
Why?
| Titanium | 2 | 2022 | 53 | 0.270 |
Why?
| Osteoclasts | 2 | 2020 | 469 | 0.270 |
Why?
| Phototherapy | 1 | 2005 | 53 | 0.260 |
Why?
| Genomics | 2 | 2021 | 310 | 0.260 |
Why?
| Polyethylene Glycols | 4 | 2021 | 106 | 0.260 |
Why?
| DNA Transposable Elements | 2 | 2021 | 82 | 0.250 |
Why?
| Inflammation | 3 | 2013 | 674 | 0.230 |
Why?
| Genes, Bacterial | 4 | 2009 | 67 | 0.220 |
Why?
| Micrococcal Nuclease | 3 | 2011 | 7 | 0.210 |
Why?
| Drug Resistance, Multiple, Bacterial | 2 | 2016 | 60 | 0.200 |
Why?
| Catheters | 3 | 2016 | 33 | 0.200 |
Why?
| Research Design | 1 | 2023 | 374 | 0.200 |
Why?
| Tissue Scaffolds | 1 | 2021 | 27 | 0.200 |
Why?
| Female | 7 | 2021 | 28441 | 0.200 |
Why?
| X-Ray Microtomography | 1 | 2021 | 82 | 0.200 |
Why?
| Debridement | 3 | 2015 | 54 | 0.200 |
Why?
| Biocompatible Materials | 2 | 2021 | 65 | 0.200 |
Why?
| Bacterial Adhesion | 4 | 2009 | 20 | 0.190 |
Why?
| Disease Susceptibility | 1 | 2021 | 95 | 0.190 |
Why?
| Chronic Disease | 2 | 2014 | 614 | 0.190 |
Why?
| Postoperative Complications | 2 | 2013 | 1033 | 0.180 |
Why?
| Polymerase Chain Reaction | 1 | 2021 | 531 | 0.180 |
Why?
| Calcium Sulfate | 2 | 2014 | 6 | 0.180 |
Why?
| Osteochondrosis | 1 | 2019 | 10 | 0.180 |
Why?
| Leukocidins | 1 | 2019 | 8 | 0.180 |
Why?
| Exotoxins | 1 | 2019 | 9 | 0.180 |
Why?
| Ciprofloxacin | 2 | 2018 | 28 | 0.180 |
Why?
| RNA, Double-Stranded | 1 | 2019 | 21 | 0.180 |
Why?
| RNA Stability | 2 | 2012 | 28 | 0.180 |
Why?
| Phagosomes | 1 | 2019 | 21 | 0.180 |
Why?
| Poultry Diseases | 1 | 2019 | 28 | 0.180 |
Why?
| Bone and Bones | 2 | 2021 | 516 | 0.180 |
Why?
| Anti-Infective Agents | 2 | 2011 | 110 | 0.170 |
Why?
| Protease Inhibitors | 2 | 2010 | 64 | 0.170 |
Why?
| Prostheses and Implants | 2 | 2019 | 61 | 0.170 |
Why?
| Macrophages, Alveolar | 1 | 2019 | 26 | 0.170 |
Why?
| Polysaccharides, Bacterial | 2 | 2010 | 19 | 0.170 |
Why?
| Temperature | 2 | 2013 | 177 | 0.170 |
Why?
| Muscle, Skeletal | 1 | 2005 | 847 | 0.160 |
Why?
| Sepsis | 1 | 2021 | 251 | 0.160 |
Why?
| Biopolymers | 1 | 2018 | 14 | 0.160 |
Why?
| Genotype | 1 | 2020 | 599 | 0.160 |
Why?
| Osteogenesis | 1 | 2021 | 377 | 0.160 |
Why?
| Coinfection | 1 | 2018 | 34 | 0.160 |
Why?
| Clarithromycin | 1 | 2017 | 40 | 0.160 |
Why?
| Gram-Negative Bacteria | 1 | 2017 | 37 | 0.150 |
Why?
| Fatty Acids, Monounsaturated | 1 | 2017 | 15 | 0.150 |
Why?
| Colony Count, Microbial | 3 | 2011 | 66 | 0.150 |
Why?
| Phosphatidylcholines | 1 | 2017 | 33 | 0.150 |
Why?
| Lipopeptides | 1 | 2017 | 64 | 0.150 |
Why?
| Tandem Mass Spectrometry | 1 | 2018 | 248 | 0.150 |
Why?
| Teicoplanin | 1 | 2016 | 4 | 0.150 |
Why?
| Glycopeptides | 1 | 2016 | 15 | 0.150 |
Why?
| Aminoglycosides | 1 | 2016 | 22 | 0.150 |
Why?
| Bone Resorption | 1 | 2019 | 326 | 0.140 |
Why?
| Materials Testing | 2 | 2014 | 62 | 0.140 |
Why?
| Catheterization | 2 | 2009 | 108 | 0.140 |
Why?
| Drug Evaluation, Preclinical | 1 | 2016 | 158 | 0.140 |
Why?
| Drug Resistance, Bacterial | 1 | 2016 | 81 | 0.130 |
Why?
| Base Sequence | 4 | 2021 | 719 | 0.130 |
Why?
| Photoacoustic Techniques | 2 | 2013 | 86 | 0.130 |
Why?
| Regulatory Sequences, Nucleic Acid | 1 | 2015 | 41 | 0.130 |
Why?
| Adaptation, Physiological | 2 | 2006 | 101 | 0.130 |
Why?
| Microscopy, Confocal | 2 | 2012 | 110 | 0.130 |
Why?
| Male | 7 | 2014 | 27334 | 0.120 |
Why?
| Amphotericin B | 1 | 2014 | 122 | 0.120 |
Why?
| Methicillin Resistance | 2 | 2011 | 25 | 0.120 |
Why?
| RNA, Antisense | 2 | 2004 | 10 | 0.120 |
Why?
| Pilot Projects | 1 | 2016 | 808 | 0.120 |
Why?
| Skin | 3 | 2016 | 469 | 0.120 |
Why?
| Cerebrospinal Fluid | 1 | 2013 | 35 | 0.110 |
Why?
| Plant Stems | 1 | 2012 | 11 | 0.110 |
Why?
| Antineoplastic Agents | 1 | 2022 | 1300 | 0.110 |
Why?
| Animals, Outbred Strains | 1 | 2012 | 13 | 0.110 |
Why?
| Transcription, Genetic | 3 | 2004 | 418 | 0.110 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 673 | 0.110 |
Why?
| Plant Leaves | 1 | 2012 | 49 | 0.110 |
Why?
| Meningoencephalitis | 1 | 2012 | 8 | 0.110 |
Why?
| Magnetite Nanoparticles | 1 | 2012 | 25 | 0.110 |
Why?
| Staphylococcus epidermidis | 1 | 2012 | 16 | 0.110 |
Why?
| Cerebrospinal Fluid Shunts | 1 | 2012 | 19 | 0.110 |
Why?
| Electrophoretic Mobility Shift Assay | 3 | 2012 | 74 | 0.110 |
Why?
| Neoplastic Cells, Circulating | 1 | 2013 | 93 | 0.110 |
Why?
| Carotenoids | 1 | 2012 | 46 | 0.110 |
Why?
| Chemical Fractionation | 1 | 2012 | 18 | 0.110 |
Why?
| Biological Assay | 1 | 2012 | 55 | 0.100 |
Why?
| Bone Remodeling | 1 | 2013 | 177 | 0.100 |
Why?
| Cell Line | 2 | 2012 | 1153 | 0.100 |
Why?
| Glycosylation | 1 | 2012 | 112 | 0.100 |
Why?
| Integrin alpha5beta1 | 1 | 2011 | 3 | 0.100 |
Why?
| Antifungal Agents | 1 | 2014 | 363 | 0.100 |
Why?
| Asteraceae | 1 | 2011 | 11 | 0.100 |
Why?
| Neoplasms | 1 | 2022 | 1316 | 0.100 |
Why?
| Lactones | 1 | 2011 | 27 | 0.100 |
Why?
| Antibiotic Prophylaxis | 1 | 2012 | 67 | 0.100 |
Why?
| Fruit | 1 | 2012 | 143 | 0.100 |
Why?
| Ribonuclease P | 1 | 2011 | 3 | 0.100 |
Why?
| Promoter Regions, Genetic | 2 | 2004 | 520 | 0.100 |
Why?
| Wound Infection | 1 | 2011 | 31 | 0.100 |
Why?
| Tobramycin | 2 | 2019 | 14 | 0.100 |
Why?
| Cell Death | 1 | 2012 | 223 | 0.100 |
Why?
| Mast Cells | 1 | 2011 | 64 | 0.100 |
Why?
| RNA Processing, Post-Transcriptional | 1 | 2011 | 29 | 0.100 |
Why?
| Bacteria | 1 | 2013 | 258 | 0.100 |
Why?
| Chromatography, Liquid | 1 | 2012 | 243 | 0.100 |
Why?
| Orthopedic Fixation Devices | 1 | 2010 | 3 | 0.100 |
Why?
| Blotting, Western | 1 | 2012 | 683 | 0.090 |
Why?
| Mass Spectrometry | 1 | 2012 | 313 | 0.090 |
Why?
| Sesquiterpenes | 1 | 2011 | 91 | 0.090 |
Why?
| Models, Animal | 1 | 2011 | 255 | 0.090 |
Why?
| Inflammasomes | 2 | 2022 | 60 | 0.090 |
Why?
| Hemolysis | 2 | 2017 | 32 | 0.090 |
Why?
| Flow Cytometry | 1 | 2013 | 546 | 0.090 |
Why?
| Bacteriophage lambda | 1 | 2009 | 12 | 0.090 |
Why?
| Lasers | 2 | 2012 | 141 | 0.090 |
Why?
| Integrases | 1 | 2009 | 45 | 0.090 |
Why?
| Phenols | 1 | 2011 | 120 | 0.090 |
Why?
| Genetic Variation | 1 | 2011 | 253 | 0.090 |
Why?
| Plankton | 2 | 2011 | 5 | 0.090 |
Why?
| Hot Temperature | 2 | 2012 | 199 | 0.090 |
Why?
| Wound Healing | 1 | 2011 | 228 | 0.090 |
Why?
| Acetoin | 1 | 2008 | 2 | 0.090 |
Why?
| Butylene Glycols | 1 | 2008 | 13 | 0.080 |
Why?
| Chemistry, Pharmaceutical | 1 | 2008 | 39 | 0.080 |
Why?
| Genetic Complementation Test | 1 | 2008 | 55 | 0.080 |
Why?
| Acute Disease | 1 | 2010 | 403 | 0.080 |
Why?
| Hydrogen-Ion Concentration | 2 | 2009 | 194 | 0.080 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2009 | 474 | 0.080 |
Why?
| Brain | 2 | 2013 | 1387 | 0.080 |
Why?
| Dose-Response Relationship, Drug | 1 | 2012 | 1476 | 0.080 |
Why?
| N-Acetylmuramoyl-L-alanine Amidase | 1 | 2007 | 6 | 0.080 |
Why?
| Bacteriological Techniques | 1 | 2007 | 38 | 0.070 |
Why?
| Regulon | 1 | 2006 | 11 | 0.070 |
Why?
| Microspheres | 1 | 2006 | 34 | 0.070 |
Why?
| Permeability | 1 | 2006 | 87 | 0.070 |
Why?
| Cell Survival | 1 | 2008 | 657 | 0.070 |
Why?
| Chromatography, High Pressure Liquid | 2 | 2018 | 377 | 0.070 |
Why?
| Soft Tissue Infections | 1 | 2006 | 10 | 0.070 |
Why?
| Microscopy, Phase-Contrast | 1 | 2005 | 16 | 0.070 |
Why?
| Surface Plasmon Resonance | 1 | 2005 | 25 | 0.070 |
Why?
| Spectrophotometry | 1 | 2005 | 36 | 0.070 |
Why?
| Matrix Metalloproteinases | 1 | 2006 | 52 | 0.070 |
Why?
| Arginine | 1 | 2007 | 182 | 0.070 |
Why?
| Microscopy, Electron, Transmission | 1 | 2005 | 87 | 0.070 |
Why?
| Microscopy, Electron | 1 | 2005 | 97 | 0.070 |
Why?
| Binding Sites | 2 | 2004 | 440 | 0.070 |
Why?
| Ultrasonics | 1 | 2005 | 32 | 0.070 |
Why?
| Microscopy | 1 | 2005 | 66 | 0.070 |
Why?
| DNA | 1 | 2009 | 581 | 0.070 |
Why?
| Spectrum Analysis, Raman | 1 | 2005 | 68 | 0.070 |
Why?
| Osteonecrosis | 1 | 2005 | 36 | 0.070 |
Why?
| Gene Deletion | 1 | 2006 | 293 | 0.070 |
Why?
| Nucleic Acid Hybridization | 1 | 2005 | 54 | 0.060 |
Why?
| Protein Transport | 1 | 2005 | 195 | 0.060 |
Why?
| Antigens, Bacterial | 1 | 2005 | 63 | 0.060 |
Why?
| Anaerobiosis | 1 | 2004 | 15 | 0.060 |
Why?
| Cytokines | 2 | 2022 | 676 | 0.060 |
Why?
| Phylogeny | 1 | 2005 | 269 | 0.060 |
Why?
| Consensus Sequence | 1 | 2003 | 25 | 0.060 |
Why?
| Mice, Inbred BALB C | 1 | 2004 | 368 | 0.060 |
Why?
| Fibroblasts | 1 | 2006 | 386 | 0.060 |
Why?
| Enhancer Elements, Genetic | 1 | 2003 | 64 | 0.060 |
Why?
| Friction | 1 | 2022 | 4 | 0.060 |
Why?
| Oligonucleotides | 1 | 2003 | 76 | 0.060 |
Why?
| Ligands | 1 | 2003 | 230 | 0.060 |
Why?
| Down-Regulation | 1 | 2004 | 388 | 0.060 |
Why?
| Surface Properties | 1 | 2022 | 79 | 0.060 |
Why?
| Molecular Imaging | 2 | 2013 | 60 | 0.050 |
Why?
| Time Factors | 2 | 2009 | 3213 | 0.050 |
Why?
| Up-Regulation | 1 | 2004 | 508 | 0.050 |
Why?
| Lipase | 1 | 2002 | 18 | 0.050 |
Why?
| Fibronectins | 1 | 2002 | 41 | 0.050 |
Why?
| Genes, Essential | 1 | 2021 | 14 | 0.050 |
Why?
| Mutagenesis, Insertional | 1 | 2021 | 28 | 0.050 |
Why?
| Gene Library | 1 | 2021 | 50 | 0.050 |
Why?
| Diagnosis, Differential | 1 | 2005 | 1136 | 0.050 |
Why?
| Mannitol | 1 | 2021 | 15 | 0.050 |
Why?
| Child | 2 | 2013 | 7341 | 0.050 |
Why?
| Collagen | 1 | 2002 | 223 | 0.050 |
Why?
| Carrier Proteins | 1 | 2002 | 359 | 0.050 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 206 | 0.050 |
Why?
| Staphylococcus | 1 | 2019 | 33 | 0.040 |
Why?
| Incidence | 1 | 2003 | 1082 | 0.040 |
Why?
| Neoplasm Proteins | 1 | 2022 | 359 | 0.040 |
Why?
| Models, Molecular | 2 | 2011 | 423 | 0.040 |
Why?
| Severity of Illness Index | 1 | 2003 | 1084 | 0.040 |
Why?
| Chickens | 1 | 2019 | 118 | 0.040 |
Why?
| Necrosis | 1 | 2019 | 208 | 0.040 |
Why?
| Protein Binding | 2 | 2012 | 736 | 0.040 |
Why?
| Paenibacillus | 1 | 2017 | 6 | 0.040 |
Why?
| Gram-Negative Bacterial Infections | 1 | 2017 | 42 | 0.040 |
Why?
| Drug Synergism | 1 | 2017 | 171 | 0.040 |
Why?
| Rats | 2 | 2015 | 3415 | 0.040 |
Why?
| Drug Combinations | 1 | 2017 | 128 | 0.040 |
Why?
| Structure-Activity Relationship | 1 | 2017 | 423 | 0.040 |
Why?
| Analysis of Variance | 1 | 2018 | 635 | 0.040 |
Why?
| Freeze Drying | 1 | 2016 | 7 | 0.040 |
Why?
| Drug Compounding | 1 | 2016 | 28 | 0.030 |
Why?
| Polytetrafluoroethylene | 1 | 2016 | 36 | 0.030 |
Why?
| Acetates | 1 | 2016 | 50 | 0.030 |
Why?
| Lung | 1 | 2019 | 507 | 0.030 |
Why?
| Molecular Sequence Data | 2 | 2009 | 980 | 0.030 |
Why?
| Porifera | 1 | 2014 | 2 | 0.030 |
Why?
| Musculoskeletal System | 1 | 2014 | 16 | 0.030 |
Why?
| Point-of-Care Systems | 1 | 2015 | 70 | 0.030 |
Why?
| Cerebral Ventricles | 1 | 2013 | 25 | 0.030 |
Why?
| Phosphorylation | 1 | 2015 | 614 | 0.030 |
Why?
| Cell Culture Techniques | 1 | 2014 | 112 | 0.030 |
Why?
| Mammary Neoplasms, Animal | 1 | 2013 | 38 | 0.030 |
Why?
| Spectrum Analysis | 1 | 2013 | 79 | 0.030 |
Why?
| Staphylococcal Protein A | 1 | 2012 | 7 | 0.030 |
Why?
| Photochemical Processes | 1 | 2012 | 10 | 0.030 |
Why?
| Staining and Labeling | 1 | 2013 | 106 | 0.030 |
Why?
| Color | 1 | 2012 | 29 | 0.030 |
Why?
| Equipment Design | 1 | 2014 | 318 | 0.030 |
Why?
| Femur | 1 | 2013 | 144 | 0.030 |
Why?
| Lipoproteins | 1 | 2012 | 45 | 0.030 |
Why?
| Complementary Therapies | 1 | 2012 | 31 | 0.030 |
Why?
| Light | 1 | 2012 | 82 | 0.030 |
Why?
| Chromatin Immunoprecipitation | 1 | 2012 | 55 | 0.030 |
Why?
| Mice, Nude | 1 | 2012 | 283 | 0.030 |
Why?
| Antibodies | 1 | 2012 | 178 | 0.030 |
Why?
| Plant Components, Aerial | 1 | 2011 | 5 | 0.030 |
Why?
| Disease Reservoirs | 1 | 2011 | 7 | 0.030 |
Why?
| Immune Evasion | 1 | 2011 | 12 | 0.030 |
Why?
| Carrier State | 1 | 2011 | 12 | 0.030 |
Why?
| Inhibitory Concentration 50 | 1 | 2011 | 80 | 0.030 |
Why?
| Cytotoxicity, Immunologic | 1 | 2011 | 62 | 0.030 |
Why?
| Hep G2 Cells | 1 | 2011 | 46 | 0.020 |
Why?
| Endocytosis | 1 | 2011 | 60 | 0.020 |
Why?
| Crystallography, X-Ray | 1 | 2011 | 178 | 0.020 |
Why?
| Tensile Strength | 1 | 2010 | 33 | 0.020 |
Why?
| Small Molecule Libraries | 1 | 2011 | 72 | 0.020 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 2011 | 253 | 0.020 |
Why?
| Molecular Structure | 1 | 2011 | 319 | 0.020 |
Why?
| Attachment Sites, Microbiological | 1 | 2009 | 3 | 0.020 |
Why?
| Sequence Alignment | 1 | 2009 | 146 | 0.020 |
Why?
| Deoxyribonuclease I | 1 | 2009 | 41 | 0.020 |
Why?
| Recombination, Genetic | 1 | 2009 | 108 | 0.020 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2011 | 434 | 0.020 |
Why?
| Protein Structure, Tertiary | 1 | 2009 | 289 | 0.020 |
Why?
| Plasmids | 1 | 2009 | 180 | 0.020 |
Why?
| Databases, Genetic | 1 | 2009 | 101 | 0.020 |
Why?
| Cell Line, Tumor | 1 | 2013 | 1550 | 0.020 |
Why?
| Oxidation-Reduction | 1 | 2009 | 382 | 0.020 |
Why?
| Amino Acid Sequence | 1 | 2009 | 767 | 0.020 |
Why?
| Immunohistochemistry | 1 | 2011 | 1089 | 0.020 |
Why?
| Escherichia coli | 1 | 2009 | 250 | 0.020 |
Why?
| Tomography, X-Ray Computed | 1 | 2013 | 1213 | 0.020 |
Why?
| Models, Biological | 1 | 2011 | 823 | 0.020 |
Why?
| Species Specificity | 1 | 2007 | 205 | 0.020 |
Why?
| Synovial Membrane | 1 | 2006 | 17 | 0.020 |
Why?
| Tissue Inhibitor of Metalloproteinases | 1 | 2006 | 11 | 0.020 |
Why?
| Half-Life | 1 | 2006 | 92 | 0.020 |
Why?
| Mitogen-Activated Protein Kinase Kinases | 1 | 2006 | 39 | 0.020 |
Why?
| Osteoarthritis | 1 | 2006 | 71 | 0.020 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 314 | 0.020 |
Why?
| Apoptosis | 1 | 2011 | 1300 | 0.020 |
Why?
| Ethidium | 1 | 2004 | 7 | 0.020 |
Why?
| Arthritis, Rheumatoid | 1 | 2006 | 130 | 0.020 |
Why?
| Gene Expression | 1 | 2006 | 664 | 0.010 |
Why?
| Drug Implants | 1 | 2002 | 35 | 0.010 |
Why?
| Cells, Cultured | 1 | 2006 | 1737 | 0.010 |
Why?
|
|
Smeltzer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|